MedPath

A clinical study on the effect of bilvadi eye drop and lauhadi guggulu in computer vision syndrome.

Phase 2
Conditions
Health Condition 1: H538- Other visual disturbances
Registration Number
CTRI/2024/06/069421
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Minimum 3 hours exposure to any type of visual display terminal like desktop, laptop or both daily.

2.Computer users complaining of eye strain, burning eyes, red eyes, dry and irritated eyes, light/glare sensitivity, headache, progressive refractive changes, redness, diplopia

3.Patients having a minimum three symptoms of CVS.

Exclusion Criteria

1.Patients not willing to participate in the study.

2.Patients suffering from infectious conditions of the eye like conjunctivitis, dry eye syndrome, scleritis, uveitis, glaucoma, stye, etc.

3.Any fundus pathology like optic atrophy, diabetic retinopathy, hypertensive retinopathy, papilledema etc.

4.Recent history of any surgical intervention to the eye.

5.Persistent contact lens users.

6.Patients suffering from uncontrolled systemic disease under medication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Improvement in signs and symptoms of computer vision syndrome i.e. Eye strain and burning eyes. <br/ ><br>2. The safety parameters of the trial drug will be assessed in RSBK department as per the facility available in the laboratory (physio-chemical parameters of the trial drug). <br/ ><br>Timepoint: 1st day, 15th day and 30th day, 60th day.
Secondary Outcome Measures
NameTimeMethod
1.Improvement in other signs and symptoms of computer vision syndrome which are Dry eyes, Blurred vision, Headache, Redness, Diplopia, Irritated eye, slow refocusing, Dizziness, Change in colour perception, Fatigue (Neck/Shoulder/Backache).Timepoint: 1st day, 15th day and 30th day, 60th day.
© Copyright 2025. All Rights Reserved by MedPath